The market reacts, overreacts, and recovers quickly these days, and a lot of it amounts to nothing. We suggest embracing the number 13 ...

SAN DIEGO, Dec. 19, 2025 /PRNewswire/ -- Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Charming Medical, Limited (NASDAQ: MCTA) securities between October 10, 2025 and November 12, 2025.  The Company claims to "enhance[] the quality of life from the inside out by integrating Traditional Chinese Medicine (TCM) wellness practices with modern technology." For more information, submit a form, email attorney Aaron Dumas, Jr., or giv ...

Calgary, Alberta--(Newsfile Corp. - December 19, 2025) - Baytex Energy Corp. (TSX: BTE) (NYSE: BTE) ("Baytex" or the "Company") today announced that it has closed the sale of its U.S. Eagle Ford Assets for net proceeds of US$2.14 billion (approximately $2.96 billion in Canadian dollars) after closing adjustments. This strategic divestiture significantly strengthens Baytex's financial position and sharpens its focus on a high-return Canadian energy platform, positioning the Company for long-term value creat ...

Core Insights - Lamb Weston Holdings, Inc. reported fiscal second-quarter earnings per share of $0.69, exceeding the Zacks Consensus Estimate of $0.67, despite a 5% decline in earnings year-over-year [1][6] - The company's revenue for the quarter reached approximately $1.62 billion, surpassing the estimated $1.59 billion, driven by an 8% increase in sales volume [2][6] - The stock experienced a significant decline of 25%, dropping to $44.70, following the earnings report due to negative market reaction to the company's full-year guidance [4][6] Financial Performance - Revenue growth was attributed to customer wins and market share gains, although the price/mix fell by 8% due to pricing and trade support challenges [2] - In North America, Lamb Weston saw an increase in EBITDA due to higher volumes and cost savings, while the International segment faced a decline in EBITDA due to increased costs [3] - The company has a price-to-earnings (P/E) ratio of approximately 15.95 and a price-to-sales ratio of about 0.97, indicating a favorable valuation relative to sales [5] Market Reaction - The market reacted negatively to the company's full-year guidance, projecting flat revenue and an 11% decrease in adjusted EBITDA at the midpoint, despite strong second-quarter performance [4] - The decline in stock price reflects investor concerns over future profitability and market conditions [4]

Vancouver, British Columbia--(Newsfile Corp. - December 19, 2025) - Atomic Minerals Corporation (TSXV: ATOM) (FSE: D08) (OTCQB: ATMMF) ("Atomic Minerals" or the "Company") is pleased to announce that the Company's common shares (the "Shares") have commenced trading on the OTCQB Venture Market (the "OTCQB") effective December 11, 2025, under the symbol "ATMMF"."Listing on the OTCQB positions Atomic Minerals with increased visibility among the American investment community and improved liquidity for its curr ...

Vancouver, British Columbia--(Newsfile Corp. - December 19, 2025) - Chesapeake Gold Corp. (TSXV: CKG) (OTCQX: CHPGF) ("Chesapeake" or the "Company") announces the grant of stock options under its Stock Option Plan to purchase an aggregate of 69,000 common shares of the Company at an exercise price of C$2.84 per share for a five-year term expiring December 19, 2030. The stock options were granted to officers of the Company. The options will vest and be exercisable immediately.About ChesapeakeChesapeake Gold ...

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Coupang, Inc. ("Coupang†or the "Company†) (NYSE:CPNG) securities during the period of August 6, 2025 through December 16, 2025, inclusive ("the Class Period†). If you suffered a loss on your Coupang investments, you have until February, 17, 2026 to request lead plaintiff appointment. For more information: [CONTACT THE FIRM IF YOU SUFFERED A LOSS] What Is ...

CoreWeave shares roared back to life today.Shares of CoreWeave (CRWV +22.64%) jumped today, finishing up 23%. The massive gain came as the S&P 500 and Nasdaq Composite gained 0.8% and 1.1%, respectively.After months of declines, CoreWeave investors rejoiced as shares finally had a big day -- recovering much of their post-peak drop -- after the stock received a buy rating from Citigroup, which renewed coverage on Thursday.NASDAQ : CRWVCoreWeaveToday's Change( 22.64 %) $ 15.32Current Price$ 83.00Key Data Poin ...

Today, Dec. 19, 2025, investors are weighing record cruise profits, a revived payout, and fresh guidance for the next cycle.NYSE : CCLCarnival Corp.Today's Change( 9.81 %) $ 2.78Current Price$ 31.12Key Data PointsMarket Cap$37BDay's Range$ 27.96 - $ 31.4852wk Range$ 15.07 - $ 32.80Volume84MAvg Vol23MGross Margin29.12 %Carnival (CCL +9.81%), which operates a fleet of over 100 cruise ships across various brands, closed Friday’s session at $31.12, up 9.8% on strong earnings, dividend news, and guidance. Carniv ...

Core Points - A Minnesota jury awarded $65.5 million to a plaintiff after finding Johnson & Johnson liable for exposing her to asbestos through its talc products, contributing to her mesothelioma diagnosis [1][2] - The trial revealed that Johnson & Johnson marketed talc-based products despite knowing the risk of asbestos contamination, which is a known carcinogen [2][4] - This verdict is considered the largest asbestos-related verdict in Minnesota's history, covering both economic and non-economic losses [5] Company Accountability - The case emphasized the need for accountability from Johnson & Johnson regarding its marketing practices and the safety of its products [4] - Evidence presented during the trial indicated that the company had knowledge for decades about the potential asbestos contamination in talc deposits but continued to promote its products as safe [4] Legal Context - The plaintiff, Anna Jean Houghton Carley, was diagnosed with mesothelioma in 2025, attributed to her exposure to Johnson & Johnson's baby powder during childhood [3] - The trial team included attorneys from Dean Omar Branham Shirley and Sieben Polk, P.A., who have previously secured significant verdicts against Johnson & Johnson related to talc products [5][6]